Berkshire Hathaway Inc

Explore how Berkshire Hathaway’s $4.9 billion Alphabet stake reshapes its tech exposure, balances risk, and signals long‑term growth strategy.

Warren Buffett to step down as Berkshire Hathaway CEO in 2025, passing the helm to Greg Abel while staying on as chairman—ensuring a smooth transition that preserves the firm’s value‑investing legacy and stability.

Discover how Berkshire Hathaway’s Q3 2025 earnings surged 34%, a record $381.7 bn cash reserve, and Buffett’s disciplined capital strategy boost shareholder value.

Discover how Berkshire Hathaway’s $381.7 billion cash surge and insurance profits drive growth, liquidity, and shareholder value.

Explore how Berkshire Hathaway’s 3‑year gains, Apple stake, and Class B death‑cross signals mask deeper risks and strategic shifts for investors.

Berkshire Hathaway is navigating a complex period of leadership transition, strategic acquisition, and shifting analyst sentiment, with its 2025 annual general meeting (AGM) set to be a key event in determining the conglomerate’s future trajectory.

Berkshire Hathaway, led by Warren Buffett, has made strategic moves into the chemical and healthcare sectors, acquiring OxyChem and investing in UnitedHealth Group, while also increasing its stake in Japanese equities, demonstrating a data-driven ap…

Berkshire Hathaway Inc. continues to demonstrate market leadership with strong stock price growth, strategic investments, and increased investor confidence under the guidance of Warren Buffett.

Berkshire Hathaway, led by Warren Buffett, has made significant portfolio adjustments in the second quarter, shifting focus from Apple and US Bank to healthcare and homebuilding sectors.